$5.92
10.84% today
Nasdaq, Apr 04, 09:16 pm CET
ISIN
SG9999014716
Symbol
WVE
Sector
Industry

Wave Life Sciences Ltd. Target price 2025 - Analyst rating & recommendation

Wave Life Sciences Ltd. Classifications & Recommendation:

Buy
91%
Hold
9%

Wave Life Sciences Ltd. Price Target

Target Price $22.91
Price $6.64
Potential
Number of Estimates 11
11 Analysts have issued a price target Wave Life Sciences Ltd. 2026 . The average Wave Life Sciences Ltd. target price is $22.91. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 11 analysts: 10 Analysts recommend Wave Life Sciences Ltd. to buy, 1 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Wave Life Sciences Ltd. stock has an average upside potential 2026 of . Most analysts recommend the Wave Life Sciences Ltd. stock at Purchase.

Sales and Margin forecast 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Revenue Million $ 108.30 69.71
4.42% 35.63%
EBITDA Margin -93.94% -275.44%
81.06% 193.20%
Net Margin -98.92% -225.53%
35.63% 128.00%

11 Analysts have issued a sales forecast Wave Life Sciences Ltd. 2025 . The average Wave Life Sciences Ltd. sales estimate is

$69.7m
Unlock
. This is
35.63% lower
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
$102m 5.82%
Unlock
, the lowest is
$35.0m 67.68%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 $108m 4.42%
2025
$69.7m 35.63%
Unlock
2026
$71.8m 3.03%
Unlock
2027
$172m 139.03%
Unlock
2028
$293m 70.64%
Unlock
2029
$445m 51.85%
Unlock

1 Analyst has issued an EBITDA forecast Wave Life Sciences Ltd. 2025 . The average Wave Life Sciences Ltd. EBITDA estimate is

$-192m
Unlock
. This is
88.72% lower
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
$-192m 88.72%
Unlock
, the lowest is
$-192m 88.72%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2024 $-102m 73.06%
2025
$-192m 88.72%
Unlock
2026
$-190m 0.87%
Unlock
2027
$-252m 32.64%
Unlock

EBITDA Margin

2024 -93.94% 81.06%
2025
-275.44% 193.20%
Unlock
2026
-265.01% 3.79%
Unlock
2027
-147.05% 44.51%
Unlock

5 Wave Life Sciences Ltd. Analysts have issued a net profit forecast 2025. The average Wave Life Sciences Ltd. net profit estimate is

$-157m
Unlock
. This is
30.03% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
$-98.0m 18.98%
Unlock
, the lowest is
$-204m 68.35%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 $-107m 29.63%
2025
$-157m 46.75%
Unlock
2026
$-163m 3.60%
Unlock
2027
$-176m 7.77%
Unlock
2028
$-113m 35.48%
Unlock
2029
$-13.8m 87.84%
Unlock

Net Margin

2024 -98.92% 35.63%
2025
-225.53% 128.00%
Unlock
2026
-226.77% 0.55%
Unlock
2027
-102.24% 54.91%
Unlock
2028
-38.66% 62.19%
Unlock
2029
-3.10% 91.98%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 to 2029

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '24 2025
Estimates
Earnings Per Share $ -0.70 -1.03
29.63% 47.14%
P/E negative
EV/Sales 10.76

5 Analysts have issued a Wave Life Sciences Ltd. forecast for earnings per share. The average Wave Life Sciences Ltd. EPS is

$-1.03
Unlock
. This is
30.38% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
$-0.64 18.99%
Unlock
, the lowest is
$-1.33 68.35%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 $-0.70 29.63%
2025
$-1.03 47.14%
Unlock
2026
$-1.06 2.91%
Unlock
2027
$-1.15 8.49%
Unlock
2028
$-0.74 35.65%
Unlock
2029
$-0.09 87.84%
Unlock

P/E ratio

Current -8.36 25.29%
2025
-6.46 22.73%
Unlock
2026
-6.24 3.41%
Unlock
2027
-5.79 7.21%
Unlock
2028
-8.97 54.92%
Unlock
2029
-73.78 722.52%
Unlock

Based on analysts' sales estimates for 2025, the Wave Life Sciences Ltd. stock is valued at an EV/Sales of

10.76
Unlock
and an P/S ratio of
14.62
Unlock
.

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 6.93 32.25%
2025
10.76 55.33%
Unlock
2026
10.45 2.94%
Unlock
2027
4.37 58.16%
Unlock
2028
2.56 41.40%
Unlock
2029
1.69 34.15%
Unlock

P/S ratio

Current 9.41 41.33%
2025
14.62 55.36%
Unlock
2026
14.19 2.94%
Unlock
2027
5.94 58.16%
Unlock
2028
3.48 41.40%
Unlock
2029
2.29 34.14%
Unlock

Current Wave Life Sciences Ltd. Upgrades & Downgrades

Create a Premium account to unlock Upgrades/Downgrades. Learn more
Analyst Rating Action Date
HC Wainwright & Co.
Locked
Locked
Locked Mar 26 2025
HC Wainwright & Co.
Locked
Locked
Locked Mar 05 2025
Jefferies
Locked
Locked
Locked Feb 25 2025
Mizuho
Locked
Locked
Locked Nov 21 2024
HC Wainwright & Co.
Locked
Locked
Locked Nov 13 2024
Truist Securities
Locked
Locked
Locked Nov 12 2024
B. Riley Securities
Locked
Locked
Locked Nov 04 2024
Analyst Rating Date
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 26 2025
Locked
HC Wainwright & Co.:
Locked
Locked
Mar 05 2025
Locked
Jefferies:
Locked
Locked
Feb 25 2025
Locked
Mizuho:
Locked
Locked
Nov 21 2024
Locked
HC Wainwright & Co.:
Locked
Locked
Nov 13 2024
Locked
Truist Securities:
Locked
Locked
Nov 12 2024
Locked
B. Riley Securities:
Locked
Locked
Nov 04 2024

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today